Yisheng Biopharma Co., Ltd.’s US$40 Million Royalty-Backed Financing From R-Bridge Healthcare Fund

Giulia Di Palma
Tagged:

Clifford Chance has advised Yisheng Biopharma Co., Ltd. on the deal, while Sidley Austin LLP and Maples and Calder advised R-Bridge Healthcare Fund.Yisheng Biopharma Co., Ltd….

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Giulia Di Palma

Author: Giulia Di Palma

…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here